(Q36939649)

17 August 2017

title

Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis (English)

1 reference

17 August 2017

main subject

cardiovascular disease

1 reference

1 reference

Johansen OE

1

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Scandinavian Journal of Clinical and Laboratory Investigation

17 August 2017

published in

1 reference

17 August 2017

volume

67

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

786-800

1 reference

The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Stroke topography and outcome in relation to hyperglycaemia and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Assessing the impact of complications on the costs of Type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Vascular multimorbidity in patients with a documented coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The epidemiology of peripheral arterial disease: importance of identifying the population at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Presentation, management, and outcomes of diabetic patients compared to non-diabetic patients admitted for acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Undiagnosed dysglycaemia and inflammation in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Abnormalities of intermediary metabolism following a gestational diabetic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Are spouses of patients with type 2 diabetes at increased risk of developing diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Microvascular complications of impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Counterpoint: impaired fasting glucose: The case against the new American Diabetes Association guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Under-diagnosis of diabetes mellitus in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The major diabetes prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The diabetes risk score: a practical tool to predict type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Preventing macrovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Inflammatory markers and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Diabetic and hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Accuracy and cost-effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Screening Coronary Arteriography in the Primary Prevention of Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Physiological severity of coronary artery stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

A systematic review of adherence with medications for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Aspirin use and counseling about aspirin among patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

The challenge of achieving national cholesterol goals in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Evaluation of risk factors for development of complications in Type II diabetes in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Randomised controlled trial of structured personal care of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Controlled trial of effect of documented cardiovascular risk scores on prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Web-based care management in patients with poorly controlled diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

Latent autoimmune diabetes in adults (LADA)—more than a name

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510701408558

10.1080/00365510701408558

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference